INNV Earnings

INNV reported its earnings on 2026-02-03, showcasing a revenue of 239.71M against an estimate of 228.40M, resulting in a 4.95% surprise. The EPS was 0.08, surpassing the expected 0.04 by 100% . The stock experienced a 37.46% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following INNV's earnings announcement on 2026-02-03, the stock price moved by 37.46% on the day of the release. Over the subsequent five days, it saw a % change. Historically, INNV's stock price tends to shift by an average of -2.85% in the 10 days leading up to earnings and +8.37% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate INNV’s annual revenue to reach 231.83M, while the EPS is projected at 0.05. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.02% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between INNV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Downward by -0.02%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, INNV's stock price typically moves by -2.85% in the 10 days before its earnings and +8.37% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.05 and revenue of 231.83M.

The earnings call reveals strong financial performance, with substantial revenue growth, improved EBITDA, and a positive net income shift. Despite some challenges, such as Q3 seasonal pressures, guidance remains optimistic with strong census growth and cost management. The Q&A highlights effective internal processes and a proactive approach to Medicaid coverage. However, management's vague responses on certain metrics and the seasonal Q3 impact temper the outlook slightly. Overall, the sentiment is positive, driven by robust financials and strategic improvements, suggesting a stock price increase in the 2% to 8% range.